Pulmonary Embolism after Vaccination with the COVID-19 Vaccine (Pfizer, BNT162b2): A Case Report

Eun-Ju Kim; Seok-Ju Yoo

doi:10.3390/vaccines11061075

Pulmonary Embolism after Vaccination with the COVID-19 Vaccine (Pfizer, BNT162b2): A Case Report

Vaccines (Basel). 2023 Jun 7;11(6):1075. doi: 10.3390/vaccines11061075.

Authors

Eun-Ju Kim¹, Seok-Ju Yoo²

Affiliations

¹ Department of Infectious Disease Control, Ulsan Metropolitan City Hall, Ulsan 44675, Republic of Korea.
² Department of Preventive Medicine, College of Medicine, Dongguk University, Gyeongju 38066, Republic of Korea.

Abstract

Pulmonary embolism causes pulmonary vascular obstruction and damages circulation, leading to death in serious cases. Various cases of thrombosis have been reported as adverse reactions after vaccination with COVID-19 vaccines, and reliable studies on thrombosis with thrombocytopenia syndrome (TTS) have been confirmed, especially for viral vector vaccines. However, the association with mRNA vaccines has not been proven. We report a case of pulmonary embolism and deep vein thrombosis that occurred after using mRNA COVID-19 vaccines (BNT162b2).

Keywords: BNT162 vaccine; COVID-19 vaccines; pulmonary embolism.

Publication types

Case Reports

Grants and funding

This research received no external funding.